Burnol?
Really complex APIs, formulations, branded segments, home diagnostics and whatnot. If growth in API happens, should cross all-time high. The stock corrected 30% even after the best Nos. Debt-free. repaid the debt of 100 Cr in last 5 yrs
expresspharma.in/latest-updates…
Really complex APIs, formulations, branded segments, home diagnostics and whatnot. If growth in API happens, should cross all-time high. The stock corrected 30% even after the best Nos. Debt-free. repaid the debt of 100 Cr in last 5 yrs
expresspharma.in/latest-updates…
Invested by looking at the complexity of API they make, believe me, I am a chemist.
Few silent features: 80% US market share in Loratidine API that's amazing. Other APIs doing well are Montelukast, Atorvastatin, Rosuvastatin, all complex.
Few silent features: 80% US market share in Loratidine API that's amazing. Other APIs doing well are Montelukast, Atorvastatin, Rosuvastatin, all complex.
3 Diabetic APIs under development. API Sales Revenue during the year 2020-21 grew by 14.74 percent at Rs. 473.95 crores with an impressive growth of 28 percent in Domestic and 10 percent in Exports. 
I am not aware of any corporate governance issue.
If you see this image, there are many players in the first two segments and very few in third because of the complexity in process development.
If you see this image, there are many players in the first two segments and very few in third because of the complexity in process development.
Google search shows the following results for one of the established brands developed by #Morepen. So if this cream has so many users, the company has a bright future!
